Dr Reddy’s Laboratories Rating- buy- Multiple issues took a toll on Q4 results
时间:2024-06-26 15:07:04 阅读(143)
Q4 results were hit by one-offs, input cost inflation, US pricing pressure and seasonally lower sales in India. Reported PAT of Rs 875 m in Q4 (-75.9% y-o-y, -87.6% q-o-q) included multiple one-offs: a) provisions of Rs 983 m in SG&A related to litigation with the State of Texas; b) Rs 390 m for the sale of two non-core brands in India and Rs 1,774 m for the sale of territorial rights for two brands in Russia and CIS; and c) impairment charges of Rs 7.6 bn mainly related to PPC-06 (R&D asset) and the Shreveport plant. Adjusting for one-offs, PAT would have been Rs 5.3 bn (-1.9% y-o-y, -25.2% q-o-q).
Overall revenues of Rs 52.2 bn (+10.4% y-o-y, -1.9% q-o-q) saw the impact of elevated pricing erosion in the US base portfolio and seasonal low sales in India. Adjusted EBITDA margins at 20.2% declined 136bps y-o-y and 244bps q-o-q in Q4 on higher input costs and US pricing woes, partially offset by cost efficiencies.
Retain Buy; lower TP to Rs 4,950 (from Rs 5,685): We retain our Buy rating on DRRD, which is making consistent progress in creating a diversified business model. It remains on track for its aspirational EBITDA margin of 25% in the next 2-3 years (adjusted margins of 20.8% in FY22) on process efficiencies and operating leverage. Its calibrated R&D efforts for differentiated generics and biosimilars also support the long-term outlook. Post Q4, we adjust our estimates in line with the current outlook, mainly for near-term cost pressure, which results in EPS cuts of 3.7%/5.9% for FY23/24e. Our revised TP is Rs 4,950 (from Rs 5,685).
上一篇:Rupee rises 14 paise to settle at 82
下一篇:Zell Education introduces global career championship; a financial education scholarship
猜你喜欢
- Rupee plunges 66 paise to drop below 83
- World Food India 2023- PM Modi inaugurates mega food event – See photos
- Year Ender 2023 - Indian Railways- Measures taken to improve safety in train operations
- Sensex breaks out of consolidation, time correction in benchmarks ongoing; Bank Nifty to reverse downtrend
- World Economic Forum 2022- India has no immediate plan to lift wheat export ban, says Piyush Goyal
- Sensex crashes 1,017 points amid global sell-off; Rupee sinks 19 paise to new low of 77
- ZEEL shares surge over 8% after NSE withdraws decision to exclude Zee Entertainment from F&O segment
- Sensex jumps 600 pts, Nifty rises 1% to reclaim 16,000; here’s what is fuelling the rally today
- Zomato, IRCTC among most sold stocks by mutual funds in May; check what shares fund managers bought & sold